Human Genome Sciences, Inc. (HGSI) – Insiders' Blog
-
Barron's Sees Human Genome (HGSI) Shares Doubling Over Next 18 Months
-
Goldman Sachs Starts Human Genome Sciences (HGSI) at Neutral, Sees Slower Benlysta Launch
-
Human Genome (HGSI) Could Become Takeover Target Upon Approval of Benlysta
-
Frontpoint Partners Said to Be Hedge Fund In SEC Tipping Case Versus a Doctor Involved with Human Genome (HGSI) Trials
-
Wall Street Hubbub 8/2: HGSI and MJN Seen As Targets, Layoffs at Barclays?, Goldman Sachs Ticks Off New Neighbors
-
'Takeover Fever' Continues In Biotech After Facet (FACT) Deal, Who's Next?
-
Human Genome (HGSI) Up On More Takeover Talk
-
Human Genome Sciences (HGSI) Climbs Higher On Takeover Speculation
-
Analysts Still Jumping on Human Genome Sciences (HGSI) Bandwagon: 3 Upgrades Today
-
After a Nearly 280% Surge In Human Genome Sciences (HGSI) Is There More Upside?
-
WHO Chief: Safe Swine Flu Vaccine Still 'Several Month's Away (NVAX, BCRX, HEB, more)
Back to HGSI Stock Lookup